Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 15

1.

Chemical composition and in vitro cytotoxic screening of sixteen commercial essential oils on five cancer cell lines.

Pistelli L, Najar B, Shortrede JE, Buhagiar J.

Chem Biodivers. 2019 Nov 12. doi: 10.1002/cbdv.201900478. [Epub ahead of print]

PMID:
31713998
2.

Frankincense essential oil suppresses melanoma cancer through down regulation of Bcl-2/Bax cascade signaling and ameliorates heptotoxicity via phase I and II drug metabolizing enzymes.

Hakkim FL, Bakshi HA, Khan S, Nasef M, Farzand R, Sam S, Rashan L, Al-Baloshi MS, Abdo Hasson SSA, Jabri AA, McCarron PA, Tambuwala MM.

Oncotarget. 2019 May 28;10(37):3472-3490. doi: 10.18632/oncotarget.26930. eCollection 2019 May 28.

3.

Cytotoxicity and apoptosis enhancement in breast and cervical cancer cells upon coadministration of mitomycin C and essential oils in nanoemulsion formulations.

Al-Otaibi WA, Alkhatib MH, Wali AN.

Biomed Pharmacother. 2018 Oct;106:946-955. doi: 10.1016/j.biopha.2018.07.041. Epub 2018 Jul 12.

PMID:
30119267
4.

Frankincense Essential Oil as a Supportive Therapy for Cancer-Related Fatigue: A Case Study.

Reis D, Jones TT.

Holist Nurs Pract. 2018 May/Jun;32(3):140-142. doi: 10.1097/HNP.0000000000000261.

PMID:
29642127
5.

Frankincense, pine needle and geranium essential oils suppress tumor progression through the regulation of the AMPK/mTOR pathway in breast cancer.

Ren P, Ren X, Cheng L, Xu L.

Oncol Rep. 2018 Jan;39(1):129-137. doi: 10.3892/or.2017.6067. Epub 2017 Nov 1.

6.

Chemical composition and biological activities of extracts and essential oil of Boswellia dalzielii leaves.

Kohoude MJ, Gbaguidi F, Agbani P, Ayedoun MA, Cazaux S, Bouajila J.

Pharm Biol. 2017 Dec;55(1):33-42. Epub 2016 Sep 21.

PMID:
27650786
7.

The use of aromasticks to help with sleep problems: A patient experience survey.

Dyer J, Cleary L, McNeill S, Ragsdale-Lowe M, Osland C.

Complement Ther Clin Pract. 2016 Feb;22:51-8. doi: 10.1016/j.ctcp.2015.12.006. Epub 2015 Dec 12.

PMID:
26850806
8.

Phytochemical Analysis and Anti-cancer Investigation of Boswellia serrata Bioactive Constituents In Vitro.

Ahmed HH, Abd-Rabou AA, Hassan AZ, Kotob SE.

Asian Pac J Cancer Prev. 2015;16(16):7179-88.

9.

The use of aromasticks at a cancer centre: a retrospective audit.

Dyer J, Cleary L, Ragsdale-Lowe M, McNeill S, Osland C.

Complement Ther Clin Pract. 2014 Nov;20(4):203-6. doi: 10.1016/j.ctcp.2013.11.006. Epub 2013 Nov 28.

PMID:
25486854
10.

Differential effects of selective frankincense (Ru Xiang) essential oil versus non-selective sandalwood (Tan Xiang) essential oil on cultured bladder cancer cells: a microarray and bioinformatics study.

Dozmorov MG, Yang Q, Wu W, Wren J, Suhail MM, Woolley CL, Young DG, Fung KM, Lin HK.

Chin Med. 2014 Jul 2;9:18. doi: 10.1186/1749-8546-9-18. eCollection 2014.

11.

Frankincense essential oil prepared from hydrodistillation of Boswellia sacra gum resins induces human pancreatic cancer cell death in cultures and in a xenograft murine model.

Ni X, Suhail MM, Yang Q, Cao A, Fung KM, Postier RG, Woolley C, Young G, Zhang J, Lin HK.

BMC Complement Altern Med. 2012 Dec 13;12:253. doi: 10.1186/1472-6882-12-253.

12.

Preparation and characterization of solid lipid nanoparticles loaded with frankincense and myrrh oil.

Shi F, Zhao JH, Liu Y, Wang Z, Zhang YT, Feng NP.

Int J Nanomedicine. 2012;7:2033-43. doi: 10.2147/IJN.S30085. Epub 2012 Apr 17.

13.

Boswellia sacra essential oil induces tumor cell-specific apoptosis and suppresses tumor aggressiveness in cultured human breast cancer cells.

Suhail MM, Wu W, Cao A, Mondalek FG, Fung KM, Shih PT, Fang YT, Woolley C, Young G, Lin HK.

BMC Complement Altern Med. 2011 Dec 15;11:129. doi: 10.1186/1472-6882-11-129.

14.

Frankincense oil derived from Boswellia carteri induces tumor cell specific cytotoxicity.

Frank MB, Yang Q, Osban J, Azzarello JT, Saban MR, Saban R, Ashley RA, Welter JC, Fung KM, Lin HK.

BMC Complement Altern Med. 2009 Mar 18;9:6. doi: 10.1186/1472-6882-9-6.

15.

Supplemental Content

Loading ...
Support Center